A new study found that women who test positive for A Parkinson-s related protein accumulated tau at a much faster rate, ...

Cognito raised $105 million as it awaits trial data that it hopes will convince the FDA to authorize its Alzheimer’s treatment device.

Hormone therapy is widely used to treat menopausal symptoms such as hot flushes and night sweats. But scientists have long ...

Scientists have developed a promising new approach to treating Alzheimer’s disease by turning ordinary brain cells into powerful plaque-clearing machines. Instead of requiring frequent antibody ...

By Daniella Parra Acumen Pharmaceuticals said it will present new research on its Alzheimer’s treatment candidate at the International Conference on Alzheimer’s and Parkinson’s Diseases 2026 in ...

Mandara Biopharma Inc. announced approval from the FDA to initiate their clinical trials for the treatment of agitation ...

Women with higher levels of p-tau217, a blood protein, were twice as likely to eventually develop dementia or mild cognitive impairment.

Alzheimer's disease affects millions of people around the world. To study this condition, researchers must peer inside the distinctive environment of the human brain. but for scientists to get the ...

A new analysis of more than 422,000 patients reveals a stark Alzheimer’s care gap between Maryland’s urban and rural communities. Rural regions often lack hospitals and dementia specialists, forcing ...